Literature DB >> 30041221

The Role of Non-Tuberculous Mycobacteria in Peritoneal Dialysis-Related Infections: A Literature Review.

Naoki Washida, Hiroshi Itoh.   

Abstract

BACKGROUND: Peritonitis is one of the most frequent reasons for withdrawal of peritoneal dialysis (PD). Although most cases of PD-related peritonitis can be treated with antibiotics, it is occasionally refractory and culture-negative.
SUMMARY: The causes of refractory PD-related peritonitis include antibiotic-resistant bacteria, fungal peritonitis, biofilm formation in PD catheters, bacterial translocation from the gastrointestinal tract, and encapsulating peritoneal sclerosis. Among them, culture-negative peritonitis is notable, and non-tuberculous mycobacteria (NTM) can be a cause of culture-negative peritonitis. In the present study, the treatment and outcomes of NTM peritonitis and exit site infections were investigated by collecting data from relevant reviews published during the last 10 years. Catheter removal was required in 92.2% of the patients with NTM peritonitis, and withdrawal of PD was performed in 91.9%. The overall mortality rate (including unrelated deaths) was 12.4% in patients with NTM peritonitis. Among patients with NTM exit site infections, 33.3% developed peritonitis, and catheter removal was required in 50.0%. A lower percentage of patients stopped PD when the catheter was removed without developing peritonitis (37.5%) than when it was removed after the onset of peritonitis (91.9%). Changing the exit site or unroofing was performed in 12.5% of the patients with NTM exit site infections. In addition, these infections resolved with antibiotics alone or without antibiotics in 18.8 and 12.5% of the patients, respectively, while 6.25% of the patients died. Key Messages: NTM peritonitis often requires catheter removal or withdrawal of PD, and the associated mortality is not low. Thus, prevention of NTM peritonitis is important. In patients with NTM exit site infections, appropriate antimicrobial therapy and/or PD catheter removal should be performed to prevent peritonitis.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30041221     DOI: 10.1159/000485716

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  4 in total

1.  Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter-related infection treated with amikacin.

Authors:  Sanae Kojya; Hideo Shiohira; Yoshitsugu Sunagawa; Shoji Tsuneyoshi; Kentaro Kohagura; Yusuke Ohya; Fusako Yonaha; Nobuo Hokama; Katsunori Nakamura
Journal:  Clin Case Rep       Date:  2020-03-11

2.  Peritoneal Dialysis-Associated Peritonitis Caused by Mycobacterium abscessus in Children-A Case Report.

Authors:  Omar Imam; Khaled Al-Zubaidi; Mohammad Janahi; Abubakr Imam; Bassil Leghrouz; Simon Dobson; Sathyavathi Sundararaju; Kin Ming Tsui; Mohammad Rubayet Hasan; Andres Perez-Lopez
Journal:  Open Forum Infect Dis       Date:  2020-11-27       Impact factor: 3.835

3.  Refractory Peritonitis and Small Bowel Ileus: A Case of Encapsulating Peritoneal Sclerosis Secondary to Mycobacterium abscessus Peritonitis.

Authors:  Soroush Rouhani; Nikesh Adunuri
Journal:  Eur J Case Rep Intern Med       Date:  2022-03-07

4.  Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival.

Authors:  Rikako Oki; Yoshifumi Hamasaki; Yohei Komaru; Yoshihisa Miyamoto; Ryo Matsuura; Daisuke Yamada; Masao Iwagami; Kent Doi; Haruki Kume; Masaomi Nangaku
Journal:  Kidney Int Rep       Date:  2020-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.